Xiangxue Pharmaceutical (300147) — Long-term Investment Intensity
Xiangxue Pharmaceutical (300147) has a Long-term Investment Intensity of 5.5% as of September 2019. Long-term investments of CN¥471.68 Million represent 5.5% of total assets of CN¥8.56 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. For the complete balance sheet picture, see 300147 asset base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Xiangxue Pharmaceutical Long-term Investment Intensity (2015–2018)
This chart shows how Xiangxue Pharmaceutical's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 5.5%, reflecting long-term investments of CN¥471.68 Million against total assets of CN¥8.56 Billion CNY. See working capital position of Xiangxue Pharmaceutical to evaluate short-term liquidity relative to the company's equity base.
Annual Long-term Investment Intensity for Xiangxue Pharmaceutical (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Xiangxue Pharmaceutical from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Xiangxue Pharmaceutical balance sheet liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 4.2% | CN¥366.19 Million | CN¥8.63 Billion | ▲ +0.7 pp |
| 2017 | 3.5% | CN¥334.89 Million | CN¥9.44 Billion | ▲ +0.2 pp |
| 2016 | 3.4% | CN¥269.61 Million | CN¥7.99 Billion | ▼ 0.0 pp |
| 2015 | 3.4% | CN¥157.16 Million | CN¥4.65 Billion | — |